The Tack-Optimized Balloon Angioplasty (TOBA) II Below-the-Knee Trial: 36-Month Results
Journal of Critical Limb Ischemia · 2023
DOI: 10.25270/jcli/clig23-00023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Critical Limb Ischemia, 2023. Verfasst von George Adams und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
To report the 36-month results of the Tack-Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) study for repair of post-percutaneous transluminal angioplasty (PTA) dissection(s) of the infrapopliteal arteries. Materials and Methods: TOBA II BTK is a prospective, multicenter, single-arm evaluation of the Tack Endovascular System (Intact Vascular, Inc., now a part of Philips Image Guided Therapy Corporation) for post-PTA BTK dissection repair. Patients with Rutherford category 3 to 5 and a post-PTA dissection(s) of the mid/distal popliteal, tibial, and/or peroneal arteries were enrolled. The primary safety endpoint was a composite of major adverse limb events (MALE) and all-cause perioperative death (POD) at 30 days. The primary effectiveness endpoint was a composite of MALE at 6 months and 30-day POD. Outcomes are reported through 36 months.
Results
TOBA II BTK enrolled 233 patients with 301 post-PTA dissection(s); all patients received 1 or more Tack implant(s) (range, 1-16). Mean age was 74.4 ± 10.0 years and 67.4% were men. Most patients had critical limb-threatening ischemia (83.7%). Kaplan-Meier freedom from MALE at 36 months + POD at 30 days was 91.6%. Freedom from clinically driven-target lesion revascularization (CD-TLR) was 69.6%. High rates of target limb salvage (TLS; 95.0%) and amputation-free survival (AFS; 64.7%) were also reported. Improvements in quality of life (QoL), mobility, and Rutherford category were sustained through 36 months.
Conclusions
The Tack Endovascular System for infrapopliteal dissection repair demonstrates durable freedom from MALE + POD and CD-TLR and high rates of TLS and AFS through 36 months. Improvements were also sustained in QoL, mobility, and Rutherford category.
Zitieren
APA
Adams, G., Lichtenberg, M., Wissgott, C., Schmidt, A., Brodmann, M., Tarra, T., & Geraghty, P. (2023). The Tack-Optimized Balloon Angioplasty (TOBA) II Below-the-Knee Trial: 36-Month Results. Journal of Critical Limb Ischemia. https://doi.org/10.25270/jcli/clig23-00023
Vancouver
Adams G, Lichtenberg M, Wissgott C, Schmidt A, Brodmann M, Tarra T, et al. The Tack-Optimized Balloon Angioplasty (TOBA) II Below-the-Knee Trial: 36-Month Results. Journal of Critical Limb Ischemia. 2023. doi:10.25270/jcli/clig23-00023
BibTeX
@article{Adams2023,
author = {Adams, George and Lichtenberg, Michael and Wissgott, Christian and Schmidt, Andrej and Brodmann, Marianne and Tarra, Trisha and Geraghty, Patrick},
title = {The Tack-Optimized Balloon Angioplasty (TOBA) II Below-the-Knee Trial: 36-Month Results},
journal = {Journal of Critical Limb Ischemia},
year = {2023},
doi = {10.25270/jcli/clig23-00023}
}
EUVIMED